National Trends in Expenditures on Glucose-Lowering Medications in U.S. Adults With Diabetes: 2000–2022

Per capita expenditures on newer medications have risen markedly. Identifying key drivers of these expenditures may enhance affordability and access to effective diabetes treatments.

Authors

Institutions

Publication Details

Journal
Diabetes Care
Published
2026-02-17
DOI
https://doi.org/10.2337/dc25-2016
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

National Trends in Expenditures on Glucose-Lowering Medications in U.S. Adults With Diabetes: 2000–2022

Yu Wang, Ping Zhang, Kai McKeever Bullard
Diabetes Care
Diabetes Treatment and Management
article

National Trends in Expenditures on Glucose-Lowering Medications in U.S. Adults With Diabetes: 2000–2022

Yu Wang, Ping Zhang, Kai McKeever Bullard
article en

Abstract

Per capita expenditures on newer medications have risen markedly. Identifying key drivers of these expenditures may enhance affordability and access to effective diabetes treatments.

Diabetes CareVol. 49(4)
Centers for Disease Control and Prevention (US), The Centers (US)
No poverty
Openalex Percentile: Top 55%
Diabetes Treatment and Management
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.